Abstract
There has been little impact on the incidence of bronchopulmonary dysplasia (BPD) despite advances in perinatal care. BPD is a syndrome of persistent respiratory insufficiency in which preterm infants continue to require supplemental oxygen and/or mechanical ventilatory support with long term implications. Although the severe “classical” form of BPD is infrequently seen, a “new” BPD though often milder continues to complicate the course of the very preterm infant. The aetiology of BPD is likely to be multifactorial, evidence now suggests that premature infants are unable to temper the inflammatory response caused by extra-uterine insults such as mechanical ventilation, sepsis and oxygen. An early increase of pro-inflammatory mediators as well as a concomitant decrease in protective antiinflammatory, antioxidant, anti-protease and growth factors have been noted soon after birth in infants who subsequently develop BPD. This imbalance of inflammation soon after birth is an important factor in the ongoing persistence of BPD and one that requires urgent further research if future preterm infants are to avoid acquiring it. This comprehensive review focuses on this critical imbalance of lung injury and healing in premature infants along with new therapeutic strategies and future implications for research.
Keywords: Bronchopulmonary dysplasia, inflammation, premature infant, newborn
Current Respiratory Medicine Reviews
Title: Bronchopulmonary Dysplasia: An Imbalance of Inflammation
Volume: 5 Issue: 3
Author(s): Alison Loughran-Fowlds, Julee Oei and Kei Lui
Affiliation:
Keywords: Bronchopulmonary dysplasia, inflammation, premature infant, newborn
Abstract: There has been little impact on the incidence of bronchopulmonary dysplasia (BPD) despite advances in perinatal care. BPD is a syndrome of persistent respiratory insufficiency in which preterm infants continue to require supplemental oxygen and/or mechanical ventilatory support with long term implications. Although the severe “classical” form of BPD is infrequently seen, a “new” BPD though often milder continues to complicate the course of the very preterm infant. The aetiology of BPD is likely to be multifactorial, evidence now suggests that premature infants are unable to temper the inflammatory response caused by extra-uterine insults such as mechanical ventilation, sepsis and oxygen. An early increase of pro-inflammatory mediators as well as a concomitant decrease in protective antiinflammatory, antioxidant, anti-protease and growth factors have been noted soon after birth in infants who subsequently develop BPD. This imbalance of inflammation soon after birth is an important factor in the ongoing persistence of BPD and one that requires urgent further research if future preterm infants are to avoid acquiring it. This comprehensive review focuses on this critical imbalance of lung injury and healing in premature infants along with new therapeutic strategies and future implications for research.
Export Options
About this article
Cite this article as:
Loughran-Fowlds Alison, Oei Julee and Lui Kei, Bronchopulmonary Dysplasia: An Imbalance of Inflammation, Current Respiratory Medicine Reviews 2009; 5 (3) . https://dx.doi.org/10.2174/157339809788922360
DOI https://dx.doi.org/10.2174/157339809788922360 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interventions to Reduce Cardiovascular Risk in Children with Type 1 Diabetes
Current Diabetes Reviews Thioredoxin-1 is a Novel and Attractive Therapeutic Approach for Various Diseases Including Cardiovascular Disorders
Cardiovascular & Hematological Disorders-Drug Targets ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke
Current Pharmaceutical Design The No-Reflow Phenomenon in the Coronary Circulation
Cardiovascular & Hematological Agents in Medicinal Chemistry The Vitamin D Neuroendocrine System as a Target for Novel Neurotropic Drugs
CNS & Neurological Disorders - Drug Targets Molecular Basis of Inflammation and Insulin Resistance in Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Clinical Significance of the Blood Pressure Changes from Day to Night
Current Hypertension Reviews Platelet Microparticles Induce Angiogenesis and Neurogenesis after Cerebral Ischemia
Current Neurovascular Research Simultaneous Bilateral Basal Ganglia Hemorrhage
Current Drug Delivery Principles of Clinical Management of Patent Ductus Arteriosus in Extremely Preterm Neonates
Current Pediatric Reviews Soluble Epoxide Hydrolase Inhibitors and Cardiovascular Diseases
Current Vascular Pharmacology TP Receptor as a Therapeutic Target in Atherosclerosis and Related Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Cognitive Impairment in Systemic Lupus Erythematosus: Prevalence and Clinical Importance
Current Rheumatology Reviews Novel Insights into Vascular Repair Mechanisms
Current Pharmaceutical Design Molecular Basis of Mineralocorticoid Receptor Action in the Nervous System
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Natural Products for the Healthy Heart (Guest Editor : Dipak K. Das)]
Current Pharmaceutical Biotechnology SIRT1 as a Novel Potential Treatment Target for Vascular Aging and Age-Related Vascular Diseases
Current Molecular Medicine Recent Patents in Pemphigus Research, Prophylaxis, Diagnosis and Treatment in USA (1988-2006)
Recent Patents on Inflammation & Allergy Drug Discovery Ketamine: New Indications for an Old Drug
Current Drug Targets Soluble RAGE-Modulating Drugs: State-of-the-Art and Future Perspectives for Targeting Vascular Inflammation
Current Vascular Pharmacology